SEC 13F Intelligence

Tudor Investment Corp Et Al / ELV

Tudor Investment Corp Et Al’s Elevance Health Inc Formerly Position

Does Tudor Investment Corp Et Al own Elevance Health Inc Formerly (ELV)? Yes25.5K shares worth $7M (+0.01% of its 13F portfolio) as of Q1 2026, down from 77.7K shares the prior filed quarter.

Position Value
$7M
Q1 2026
Shares
25.5K
% of Portfolio
+0.01%
Quarters Held
19
currently held

Position History ELV

Reported value by quarter
Q1 ’19: $3MQ1 ’19Q3 ’19: $11MQ4 ’19: $4MQ1 ’20: $2MQ1 ’20Q2 ’20: $4MQ3 ’20: $3MQ4 ’20: $2MQ4 ’20Q2 ’21: $4MQ3 ’21: $1MQ1 ’22: $2MQ1 ’22Q2 ’22: $13MQ3 ’22: $19MQ1 ’23: $1,840Q1 ’23Q2 ’23: $7MQ3 ’23: $1MQ3 ’24: $21MQ3 ’24Q4 ’24: $14MQ3 ’25: $25MQ1 ’26: $7MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202625.5K$7M+0.01%
Q3 202577.7K$25M+0.04%
Q4 202437.0K$14M+0.05%
Q3 202441.2K$21M+0.08%
Q3 20233.0K$1M+0.01%
Q2 202315.4K$7M+0.08%
Q1 20234.0K$1,840+0.03%
Q3 202241.4K$19M+0.41%
Q2 202227.9K$13M+0.35%
Q1 20223.5K$2M+0.04%
Q3 20213.3K$1M+0.02%
Q2 202110.9K$4M+0.08%
Q4 20206.6K$2M+0.06%
Q3 202012.7K$3M+0.15%
Q2 202014.6K$4M+0.19%
Q1 20208.9K$2M+0.18%
Q4 201913.9K$4M+0.19%
Q3 201946.8K$11M+0.39%
Q1 20199.2K$3M+0.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tudor Investment Corp Et Al’s full portfolio or all institutional holders of ELV.